Neuropsychiatry

The experts weighed in on a wide variety of psychiatric issues for the August 2022 issue of Psychiatric Times.

These are the extra figures for John J. Miller, MD's article, "Serotonin: A Biography" from the 2022 September issue.

What are the long term psychiatric and neuropsychiatric complications of COVID-19?

Is the term, "extrapyramidal symptoms," an example of a “4-letter word”?

An estimated 5% to 10% of acute psychiatric inpatients have catatonia—yet catatonia remains widely underdiagnosed.

Survey results addressed connections between migraine and mental health, stigma, and treatment preferences.

Is our research about Alzheimer disease wrong?

How prioritizing brain health and brain skills could offer new solutions to this challenge.

"The young and exciting field of psychiatric pharmacogenomics is providing a third pillar of understanding to aid in our competent and informed prescribing of drugs, joining the more well-established pillars of pharmacokinetics and pharmacodynamics."

Understanding the intersection between substance misuse and acquired brain injury can assist clinicians in accurately diagnosing and treating these cooccurring conditions.

Over the past 6 months, Psychiatric Times has featured expert opinions on important psychiatric issues from psychosis to psychedelics.

Catch up on the latest research on ADHD, PTSD, and more with Psychiatric Times.

Despite its prevalence and clinical impact, catatonia remains widely underdiagnosed. What are clinicians missing?

An expert discusses the effects of long COVID on the brain at the 2022 APA Annual Meeting.

Is it ADHD—or something else? The importance of careful assessment for the proper diagnosis and effective treatment of the third most common mental health disorder worldwide.

The neuropsychiatric implications of stroke are vast. Here's what you need to know to support your patients.

The 2022 APA Annual Meeting highlights the latest guidelines for these treatments, plus recommendations for updates and improvements.

Experts address cognitive dysfunction found in patients with long COVID at the 2022 APA Annual Meeting.

What are the neuropsychiatric effects of sparring in mixed martial arts? New research presented at the 2022 APA Annual Meeting elucidates the issues.

What are the neuropsychiatric effects of COVID-19, and how can we study them further?

Compelling new book discusses love, Alzheimer disease, and medical aid in dying.

"Physiologically speaking, what is a thought?” The truth is, we have been unable to answer this question—until now.

One author shares his experience with suicidal, psychotic depression and the life events that he connects to its origins.

To help bring attention to what can be a preventable disability, and to focus on ways to support patients with brain injury, March is commemorated as Brain Injury Awareness Month.

Researchers explore the psychiatric and neurological etiologies of visual hallucinations.

Karl Deisseroth's new book is a compelling, educational experience for readers.

Remembering Lissy Jarvik, MD, PhD—a pioneer of geriatric neuropsychiatry.

Psychiatric disorders affect 1 in 3 individuals with epilepsy—and their etiology is multifactorial.

The experts weighed in on a wide variety of psychiatric issues for the Psychiatric Times February 2022 issue.

Smart phones have the potential to be either a useful and highly constructive asset or a destructive and harmful diversion from life.